BMRN vs NGS · P/E 40, rev $1.76B vs P/E 18, rev $99.9M
Biomarin Pharmaceutical Inc (BMRN) versus Natural Gas Services Group Inc (NGS) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Natural Gas Services Group Inc (NGS) is a oil & gas equipment & services company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported NGS revenue for 2026-06-30 was $99.9M. Net income was $10.6M. NGS currently screens at market cap $309.5M and trailing P/E 18.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. NGS currently screens at market cap $309.5M and trailing P/E 18.4.
Not investment advice. Open the BMRN and NGS stock pages for the full models.
Not investment advice.